Updated on 28/04/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 4.8 - Undesirable Effects
-
Change to section 5.3 - Preclinical Safety Data
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 15-Apr-2011 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| To make a minor change to section 4.8 (Undesirable effects) and to update section 4.6 (Pregnancy and lactation) to remove reference to section 5.3.
|
|
Updated on 13/04/2011 and displayed until 28/04/2011
|
Reasons for adding or updating:
|
-
Change to section 5.3 - Preclinical Safety Data
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 22-Mar-2011 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| update to SPC section 5.3 Preclinical safety data
|
|
Updated on 21/03/2011 and displayed until 13/04/2011
|
Reasons for adding or updating:
|
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 08-Mar-2011 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Update to section 4.6 Pregnancy and lactation of the SmPC
Ketoconazole
|
|
Updated on 26/08/2010 and displayed until 21/03/2011
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 20-Aug-2010 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Nature of change: To update section 4.8 (Undesirable effects) of the SPC, to include hypersensitivity and angioedema.
|
|
Updated on 17/06/2010 and displayed until 26/08/2010
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 02-Jun-2010 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
Change:
Update to section 4.8 (Undesirable effects) of the SPC.
|
|
Updated on 30/03/2010 and displayed until 17/06/2010
|
Reasons for adding or updating:
|
-
Change to section 6. 5 - Nature and Contents of Container
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 25-Feb-2010 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Update to 6.5 removal of sachets.
|
|
Updated on 22/03/2010 and displayed until 30/03/2010
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.9 - Overdose
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 25-Feb-2010 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Changes to section 4.4 and 4.9
|
|
Updated on 26/01/2010 and displayed until 22/03/2010
|
Reasons for adding or updating:
|
-
Change to section 6. 5 - Nature and Contents of Container
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 05-Jan-2010 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change – to section 6.5 nature and contents of container – deletion of all reference to sachets
|
|
Updated on 05/02/2009 and displayed until 26/01/2010
|
Reasons for adding or updating:
|
-
Joint SPC superseded by SPCs for individual presentations
-
Change to section 4.8 - Undesirable Effects
|
| Date of revision of text on the SPC: 21-Jan-2009 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
To update section 4.8 in line with SmPC guidelines.
To provide separate SmPCs for Nizoral Dandruff Shampoo (P) and Nizoral Antidandruff Shampoo (GSL).
|
|
Updated on 15/12/2008 and displayed until 05/02/2009
|
Reasons for adding or updating:
|
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-Dec-2008 |
| Legal Category: P, GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
Change to section 10 – Date of revision of the text
|
December 2008
|
|
Change to section 4.6 – Pregnancy and Lactation
|
New information:
There are no adequate and well-controlled studies in pregnant or lactating women. To date, no other relevant epidemiological data are available. Data on a limited number of exposed pregnancies indicate no adverse effects of topical ketoconazole on pregnancy or on the health of the foetus/newborn child. Animal studies have shown reproductive toxicity following oral administration of ketoconazole. (see Preclinical safety data, section 5.3). No effects on the breastfed newborn/infant are anticipated. See Pharmacokinetic properties, section 5.2
|
|
|
Updated on 20/10/2008 and displayed until 15/12/2008
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contraindications
|
| Date of revision of text on the SPC: 01-Sep-2008 |
| Legal Category: P, GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
X
|
Change to section 4.3 – Contra-indications
|
Updated information
|
|
|
Updated on 23/09/2008 and displayed until 20/10/2008
|
Reasons for adding or updating:
|
-
Change to section 5.2 - Pharmacokinetic Properties
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-Sep-2008 |
| Legal Category: P, GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
X
|
Change to section 5.2 - Pharmacokinetic properties
|
Updated information
|
|
X
|
Change to section 10 – Date of revision of the text
|
September 2008
|
|
|
Updated on 18/06/2007 and displayed until 23/09/2008
|
Reasons for adding or updating:
|
-
Change to section 1 -Name of the Medicinal product
-
Change to section 2 - Qualitative and quantitative composition
-
Change to section 3 - Pharmaceutical form
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 06/2007 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
Change to section 1 –Name of the medicinal product
|
Removed TM
|
|
Change to section 2 – quantitative and qualitative composition
|
For excipients, see 6.1
|
|
Change to section 3 – pharmaceutical form
|
Shampoo
|
|
Change to section 10 – Date of revision of the text
|
June 2007
|
|
|
Updated on 27/11/2006 and displayed until 18/06/2007
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.8 - Undesirable Effects
-
Change to section 6. 4 - Special Precautions for Storage
-
Change to section 9 - Date of first Authorisation/renewal of the Authorisation
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 11/2006 |
| Legal Category: GSL/P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
4.4
|
Special Warnings and Precautions for Use
|
Add in new paragraph about gradual withdrawal.
|
|
4.5
|
Interaction with other medicinal products and other forms of interaction
|
Delete paragraph replace with None Known
|
|
4.8
|
Undesirable effects
|
Add sentence about alopecia
|
|
6.4
|
Special precautions for storage
|
Change heading
|
|
9.
|
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
|
Date of Renewal 16th September 2005
|
|
10.
|
DATE OF REVISION OF THE TEXT
|
The date here should be November 2006
|
|
|
Updated on 27/02/2006 and displayed until 27/11/2006
|
Reasons for adding or updating:
|
-
Change to section 6. 4 - Special Precautions for Storage
-
Change to section 6. 5 - Nature and Contents of Container
-
Change to section 10 (date of (partial) revision of the text
-
Correction of spelling/typing errors
|
|
Updated on 20/02/2003 and displayed until 27/02/2006
|
Reasons for adding or updating:
|
-
Change to section 1 - trade name
-
Change to section 4.1 - Therapeutic Indications
-
Change to section 4.2 - Posology and Method of Administration
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
-
Change to section 4.8 - Undesirable Effects
-
Change to section 5.1 - Pharmacodynamic Properties
-
Change to section 6. 5 - Nature and Contents of Container
-
Change to section 10 (date of (partial) revision of the text
|
|